A graduate of M.I.T. , Pat N. Confalone obtained a Ph.D. at Harvard  with Nobel laureate Prof. R.B. Woodward. After a post doctoral stint , also with Prof. R.B. Woodward, directed toward the total synthesis of Vitamin B12, he joined the Chemical Research Department of Hoffmann-La Roche . Moving to Dupont , he contributed to the development of fluorescent DNA sequencing reagents employed in the human genome project, CozaarTM, a major anti-hypertensive based on angiotensin II antagonism and SustivaTM, a highly successful NNRTI used to treat AIDS. As Vice President, Global R&D, DuPont Crop Protection, he oversaw the successful development of Rynaxypyr™, the world’s safest insecticide and a huge blockbuster in agrichemicals. Total sales of these major life science products exceed $30 billion to-date. Dr. Confalone has presented >110 invited or plenary lectures worldwide, published >140 papers and obtained >50 U.S. Patents. He has received numerous honors and awards, including the Harvard Graduate Society Prize, the Alpha Chi Sigma Award, and was nominated to the Harvard Society of Fellows. Dr. Confalone is on Editorial Advisory Boards of Current Drugs, Bioorganic and Medicinal Chemistry, The Journal of Organic Chemistry, Synlett, Progress in Heterocyclic Chemistry, Synthesis, Medicinal Chemistry Research, Medicinal Chemistry Letters, and Drug Design and Discovery. He was elected chair of the Organic Division of the ACS, chair of the ACS Committee on Chemistry and Public Affairs, and was recently re-elected to the ACS Board of Directors. He is on the Board of Directors of the Council for Chemical Research, the Delaware Technology Park, the Green Chemistry Institute, the United States National Committee for IUPAC, and is an elected Fellow of the American Association for the Advancement of Science.